IDH-mutant glioma is a molecularly defined brain tumor that often behaves differently from IDH-wildtype glioblastoma. This article explains what IDH mutation means, prognosis, vorasidenib eligibility, surgery, MRI follow-up, radiation, chemotherapy, recurrence risk, and how integrative Ayurvedic support may help patients improve strength, quality of life, and treatment tolerance under proper medical supervision.